Torsdag 4 September | 05:26:36 Europe / Stockholm

Kalender

Est. tid*
2025-08-28 - Kvartalsrapport 2025-Q2
2025-06-02 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2025-05-29 - Årsstämma
2025-04-29 - Bokslutskommuniké 2024
2025-02-12 - Extra Bolagsstämma 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15 - Årsstämma
2024-05-07 - Bokslutskommuniké 2023
2023-10-11 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-09-29 - Kvartalsrapport 2022-Q2
2022-09-02 - Extra Bolagsstämma 2022
2022-05-19 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.
2025-09-01 08:41:01

NEWS RELEASE

Copenhagen, Denmark, 1 September 2025 – Brain+ A/S (Nasdaq First North: BRAINP)

Brain+ A/S (“Brain+” or the “Company”) will host a live webinar on Thursday, 4 September 2025 at 15:30 CEST / 14:30 BST to present the Company’s report for the Half Year 2025. The report was published on Thursday, 28 August 2025. To register for the webinar and post questions to management in advance, click here.

Participants from Brain+ will be CEO Devika Wood, SVP for Partnerships Fiona Costello and CFO Hanne Vissing Leth, who will present highlights of the report and provide details on commercial activities as well as on sales and financial outlook.

Brain+’ published its report for the Half Year 2025 on Thursday 28 August 2025 after market close. To present the report and provide further details on the status and outlook for the business with special focus on commercial activities, sales expectations and financial outlook, the Company invites its shareholders, other investors and stakeholders to a webinar.

Event Details

  • Title: Presentation of Half Year 2025 report: Focus on commercial activities and sales outlook
  • Date: Thursday, 4 September 2025
  • Time: 15:30 – 16:30 CEST / 14:30 – 15:30 BST
  • Location: Online (Stokk.io)
  • To register and ask questions in advance: Click here
  • Participants from Brain+: CEO Devika Wood; SVP, Partnerships Fiona Costello and CFO Hanne Vissing Leth.

---

About Brain+

Brain+ A/S is a digital health company listed on Nasdaq First North Growth Market Denmark, building the world’s first scalable dementia care platform. Its flagship product, Ayla - your CST Assistant, is a solution designed to support the consistent delivery of high-quality Cognitive Stimulation Therapy (CST), a non-pharmacological, NICE-recommended intervention for people with mild to moderate dementia.

 

Contact Information

Devika Wood, CEO: + 44 7429 280366, [email protected]

Hanne Vissing Leth, CFO: +45 53 88 99 02, [email protected]

Brain+ vision: Building the world’s first scalable dementia care platform to help people affected by dementia, live better lives.